Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Use of RNAi inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer
2003 (English)Patent (Other (popular science, discussion, etc.))
Place, publisher, year, edition, pages
2003.
Identifiers
URN: urn:nbn:se:su:diva-20278OAI: oai:DiVA.org:su-20278DiVA: diva2:186804
Note
Licensed to KuDOS Pharmaceuticals Ltd. (KuDOS now sold to AstraZeneca Ltd)Available from: 2007-11-23 Created: 2007-11-23Bibliographically approved

Open Access in DiVA

No full text

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 12 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf